依折麦布联合氟伐他汀对冠心病患者的降脂效果观察
2015-01-31杜颖韩丽华
杜颖 韩丽华
依折麦布联合氟伐他汀对冠心病患者的降脂效果观察
杜颖韩丽华
【摘要】目的 探讨依折麦布联合氟伐他汀对冠心病患者降脂的临床效果。方法 将72例冠心病患者分为两组,对照组给予氟伐他汀治疗,观察组给予依折麦布联合氟伐他汀治疗,观察两组疗效。结果 两组患者血脂水平临床指标相较治疗前均有所下降,P<0.05,差异具有统计学意义,同时观察组患者下降程度高于对照组,P<0.05,差异具有统计学意义。结论 依折麦布联合氟伐他汀在冠心病患者降脂治疗中的应用效果显著。
【关键词】依折麦布;氟伐他汀;冠心病;降脂
作者单位:134300吉林省白山市通化矿业集团道清矿医院
Observation Lipid-lowering Effect of Ezetimibe Combine With Fluvastatin in Patients With Coronary Heart Disease
DU Ying HAN Lihua Baishan City The Tonghua Mining Group Daoqingkuang Hospital in Jilin Province, Baishan 134300, China
[Abstract]Objective To explore the lipid-lowering effect of ezetimibe combine with fluvastatin in patients with coronary heart disease. Methods Selected 72 patients with coronary heart disease were divided into two groups, the control group given fluvastatin statin therapy, the observation group was given according to fold the ezetimibe with fluorine cut statin therapy, observed the curative effect of the two groups. Results Two groups of patients with blood lipid levels in clinical indicators intersection before treatment were decreased, P<0.05, had difference statistically significance, and at the same time observation group of patients decline was higher than the control group, P<0.05, had difference statistically significance. Conclusion According to fold the ezetimibe combine fluvastatin statins lipid-lowering therapy in patients with coronary heart disease is remarkable.[Key words]Ezetimibe, Fluvastatin, Coronary heart disease, Blood lipid
冠状动脉粥样硬化性心脏病简称冠心病,是冠状动脉血管出现粥样硬化病变引发血管腔狭窄、阻塞,导致心肌缺血、缺氧、坏死的心脏病。冠心病类型丰富、范围广阔、病发原因众多,血脂代谢紊乱是引发冠心病的一项重要危险因素,其与冠心病有着极为密切的联系[1]。探讨依折麦布联合氟伐他汀对冠心病患者降脂治疗的临床效果,具体报告如下。
1 资料与治疗
1.1临床资料
选取我院2013年2月~2014年3月收治的冠心病患者72例,采用随机数字表法分为观察组以及对照组,各36例。其中对照组男25例,女11例,年龄45~75岁,平均年龄(58.7±9.4)岁;观察组中男23例,女13例,年龄46~78岁,平均年龄(59.6±10.1)岁。所有患者均行冠状动脉造影检查确诊为冠心病,同时均排除有肝脏、肾脏严重功能障碍、高血压、糖尿病等并发症、对他汀类药物过敏患者。……
